デフォルト表紙
市場調査レポート
商品コード
1458171

腫瘍情報システムの世界市場規模、シェア、成長分析:製品別、用途別、エンドユーザー別 - 産業予測(2024~2031年)

Global Oncology Information Systems Market Size, Share, Growth Analysis, By Product, By Application, By End User - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
腫瘍情報システムの世界市場規模、シェア、成長分析:製品別、用途別、エンドユーザー別 - 産業予測(2024~2031年)
出版日: 2024年03月24日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の腫瘍情報システムの市場規模は、2022年に25億米ドルとなり、2023年の27億米ドルから、2031年までには49億6,000万米ドルに成長し、予測期間中(2024~2031年)にCAGR7.9%で成長する見通しです。

市場拡大を促進すると予想される主な要因としては、世界のがん罹患率の上昇、がん治療法およびソリューションの開発に関連するコストの上昇、ヘルスケア施設によるOIS治療法の普及が挙げられます。percancer.orgによると、2021年までに米国だけで190万人近くのがん患者が増えると予想されています。治療方針を根本的に変える可能性のある数多くの新技術が開発中です。患者データと情報管理のプロセスを合理化するためのOISソフトウェアに対するニーズが高まっているため、さまざまな形態のOISソフトウェアの必要性が高まっています。市場の拡大には、企業のがん研究への投資拡大が寄与すると予想されます。市場は今後数年で大きく成長すると予想され、企業は新規性の高い技術製品の開発に積極的に投資しています。大企業によるOIS開発への投資は、ヘルスケア分野、特にがん検出分野への資本と資源の大幅な流入により、大きな可能性を持つと思われます。2024年から2025年までに、英国政府は研究開発に260億米ドルを投資する計画です。政府のライフサイエンスビジョン&がん研究プログラムは、ライフサイエンス局から1億2,350万米ドルの助成を受けています。このようなイニシアチブは、さまざまな企業による新しいソフトウェアや製品の導入とともに、市場の成長を促すはずです。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

腫瘍情報システムの世界市場:製品別

  • 市場概要
  • ソリューション
  • プロフェッショナルサービス

腫瘍情報システムの世界市場:用途別

  • 市場概要
  • 腫瘍内科
  • 放射線腫瘍学
  • 外科腫瘍学

腫瘍情報システムの世界市場:エンドユーザー別

  • 市場概要
  • 病院・画像診断センター
  • アブレーションケアセンター・がんケアセンター
  • 政府機関
  • 研究施設

腫瘍情報システムの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • Epic Systems Corporation
  • Cerner Corporation
  • Elekta AB
  • Varian Medical Systems, Inc.
  • Philips Healthcare
  • McKesson Corporation
  • GE Healthcare
  • Siemens Healthineers
  • Accuray Incorporated
  • RaySearch Laboratories AB
  • CureMD Healthcare
  • Flatiron Health, Inc.
  • MIM Software Inc.
  • Elekta Inc.
  • IBM Watson Health
  • Impac Software(Varian)
  • EpicCare Oncology
  • RayCare(RaySearch)
  • MOSAIQ Oncology(Elekta)
  • OncoEMR(CureMD)
目次
Product Code: SQMIG35A2458

Global Oncology Information Systems Market size was valued at USD 2.5 billion in 2022 and is poised to grow from USD 2.7 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

Some of the major drivers anticipated to propel market expansion are the rising incidence of cancer worldwide, rising costs associated with developing cancer therapies and solutions, and the growing uptake of OIS cures by healthcare facilities. By 2021, nearly 1.9 million more cases of cancer are anticipated to be discovered in the US alone, according to percancer.org. Numerous novel technologies are under development that could fundamentally alter the course of treatment. The necessity for various forms of OIS software has increased due to the growing need for OIS software to help streamline the process of patient data and information management. Market expansion is anticipated to be aided by companies' increased investment in cancer research. It is anticipated that the market will grow greatly in the upcoming years, and businesses are actively investing in the development of novel, highly technology products. Large companies' investments in OIS development will have enormous potential due to a significant influx of capital and resources for the healthcare sector, especially in the area of cancer detection. By 2024-2025, the UK government plans to invest $26 billion in research and development. The government's Life Sciences Vision & cancer research program has received a grant of USD 123.5 million from the Office for Life Sciences. Such initiatives, along with the introduction of new software and products by different businesses, should encourage market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Information Systems Market Segmental Analysis

Global Oncology Information Systems Market is segmented based Product, Application, End User and region. Based On Product the market is segmented into Solutions, Professional Services. Based on Application the market is segmented into Medical Oncology, Radiation Oncology, Surgical Oncology. Based on End User the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities. Based on region the global Oncology Information Systems Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Oncology Information Systems Market

The capabilities of OIS have been significantly improved by the ongoing developments in healthcare technology, including the incorporation of big data analytics, machine learning, and artificial intelligence (AI). Better patient outcomes, tailored treatment plans, and more precise diagnoses are made possible by these technological advancements.

Restraints in the Global Oncology Information Systems Market

OIS implementation and upkeep can be costly, particularly for smaller healthcare facilities. Organizations with limited funds may face difficulties covering the initial outlay, software licensing, physical infrastructure, training, and continuing maintenance expenses.

Market Trends of the Global Oncology Information Systems Market

The use of cloud-based cancer information systems by healthcare professionals is becoming more and more common. Cloud-based solutions enable healthcare organizations to securely store and retrieve patient data from any location, all while offering scalability, flexibility, and cost effectiveness. It also makes it easier for the many parties engaged in cancer care to collaborate and share data in an easy way.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Oncology Information Systems Market by Product

  • Market Overview
  • Solutions
  • and Professional Services

Global Oncology Information Systems Market by Application

  • Market Overview
  • Medical Oncology
  • Radiation Oncology
  • and Surgical Oncology

Global Oncology Information Systems Market by End User

  • Market Overview
  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • and Research Facilities

Global Oncology Information Systems Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Epic Systems Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accuray Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RaySearch Laboratories AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CureMD Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flatiron Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MIM Software Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Watson Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Impac Software (Varian)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EpicCare Oncology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RayCare (RaySearch)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MOSAIQ Oncology (Elekta)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OncoEMR (CureMD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments